Form D Explorer
Inmedix, Inc. · CIK 1851853

Report a data issueCitable research briefCompare issuerPrivate research collection

Inmedix, Inc.

CIK 1851853 · Corporation · Inc. DELAWARE · NORMANDY PARK, Washington · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Oct 6, 2025
through Oct 22, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 6, 2025 · DOct 22, 2026 · D/ALater minus earlier
Reported offering amount$5,000,000$5,000,000$0
Reported amount sold$159,980$4,009,945$3,849,965
Reported investor count—34—
Reported minimum investment$50,000$50,000$0

Earlier SEC source: 0001851853-25-000002 · Later SEC source: 0001851853-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Oct 22, 2026

Reported offering amount
$5,000,000
Reported exemptions
Rule 506(c)
Reported amount sold
$4,009,945

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)